147 related articles for article (PubMed ID: 37106289)
1. [Tumor cell-based glycolytic metabolism and single-cell sequencing of urinary exfoliated cells for the diagnosis and molecular profiling of urothelial carcinoma].
Xiao XY; Zhao H; Guo HQ; Wang C; Sun Y; Chang XX; Zhao LL; Zhang ZH
Zhonghua Bing Li Xue Za Zhi; 2023 May; 52(5):472-479. PubMed ID: 37106289
[No Abstract] [Full Text] [Related]
2. Fluorescence in situ hybridization (FISH) in the diagnosis of bladder and upper tract urothelial carcinoma: the largest single-institution experience to date.
Gomella LG; Mann MJ; Cleary RC; Hubosky SG; Bagley DH; Thumar AB; McCue PA; Lallas CD; Trabulsi EJ
Can J Urol; 2017 Feb; 24(1):8620-8626. PubMed ID: 28263126
[TBL] [Abstract][Full Text] [Related]
3. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of a comprehensive, urothelial carcinoma-specific next-generation sequencing panel in urine cytology and bladder tumor specimens.
Sun T; Hutchinson L; Tomaszewicz K; Caporelli ML; Meng X; McCauley K; Fischer AH; Cosar EF; Cornejo KM
Cancer Cytopathol; 2021 Jul; 129(7):537-547. PubMed ID: 33539671
[TBL] [Abstract][Full Text] [Related]
5. Combined application of cytology and molecular urine markers to improve the detection of urothelial carcinoma.
Todenhöfer T; Hennenlotter J; Esser M; Mohrhardt S; Tews V; Aufderklamm S; Gakis G; Kuehs U; Stenzl A; Schwentner C
Cancer Cytopathol; 2013 May; 121(5):252-60. PubMed ID: 23172833
[TBL] [Abstract][Full Text] [Related]
6. [Clinical value of fluorescence in situ hybridization positive of exfoliated urothelial cells in urothelial carcinoma].
Liu JY; Peng X; Ning XH; Li T; Peng SH; Wang JY; Liu SJ; Ding Y; Cai L; Gong K
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Aug; 49(4):585-589. PubMed ID: 28816270
[TBL] [Abstract][Full Text] [Related]
7. The use of urinary nuclear matrix protein 22 (NMP22) as a diagnostic adjunct to urine cytology for monitoring of recurrent bladder cancer--institutional experience and review.
Önal B; Han Ü; Yilmaz S; Köybasioglu F; Altuğ U
Diagn Cytopathol; 2015 Apr; 43(4):307-14. PubMed ID: 25488052
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of MCM5 (ADXBLADDER) analysis in urine of men evaluated for the initial diagnosis of bladder cancer: A comparative prospective study.
Anastasi E; Maggi M; Tartaglione S; Angeloni A; Gennarini G; Leoncini PP; Sperduti I; Di Lascio G; De Stefano V; Di Pierro GB; Del Giudice F; Busetto GM; De Berardinis E; Sciarra A
Diagn Cytopathol; 2020 Nov; 48(11):1034-1040. PubMed ID: 32562513
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity of urine cytology in detecting high-grade urothelial carcinoma in patients with neoplastic urinary bladder diverticula: A major cancer center experience.
Alhamar M; Al-Ahmadie HA; Feratovic R; Lin O
Cancer Cytopathol; 2024 Mar; 132(3):144-151. PubMed ID: 38054371
[TBL] [Abstract][Full Text] [Related]
10. Single-Cell Sequencing-Enabled Hexokinase 2 Assay for Noninvasive Bladder Cancer Diagnosis and Screening by Detecting Rare Malignant Cells in Urine.
Wang Z; Chen J; Yang L; Cao M; Yu Y; Zhang R; Quan H; Jiang Q; Hua Y; Wei W; Lu P; Wu J; Shi Q
Anal Chem; 2020 Dec; 92(24):16284-16292. PubMed ID: 33269906
[TBL] [Abstract][Full Text] [Related]
11. Letter to the Editor: clinical utility of urine DNA for noninvasive detection and minimal residual disease monitoring in urothelial carcinoma.
Yang K; Hu H; Wu J; Wang H; Guo Z; Yu W; Yao L; Ding F; Zhou T; Wang W; Wang Y; Liu L; Guo J; Zhu S; Zhang X; Cao S; Lou F; Niu Y; Ye D; He Z
Mol Cancer; 2023 Feb; 22(1):25. PubMed ID: 36739413
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic brush cytology of the upper urinary tract. Evaluation of its efficacy and potential limitations in diagnosis.
Dodd LG; Johnston WW; Robertson CN; Layfield LJ
Acta Cytol; 1997; 41(2):377-84. PubMed ID: 9100770
[TBL] [Abstract][Full Text] [Related]
13. Detection of Copy Number Imbalance in Canine Urothelial Carcinoma With Droplet Digital Polymerase Chain Reaction.
Mochizuki H; Shapiro SG; Breen M
Vet Pathol; 2016 Jul; 53(4):764-72. PubMed ID: 26574558
[TBL] [Abstract][Full Text] [Related]
14. [Value of CK20 immunocytochemistry as an adjuvant to urine liquid-based cytology in detection of urothelial carcinoma].
Li M; Li HX; Guo HQ; Zhao H; Zhao LL; Ma JH; Li CL; Cao J; Pan QJ
Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):669-73. PubMed ID: 23159079
[TBL] [Abstract][Full Text] [Related]
15. UBC®Rapid Is Sensitive in Detecting High-Grade Bladder Urothelial Carcinoma and Carcinoma in situ in Asian Population.
Zang Z; Kesavan NR; Esuvaranathan K
Urol Int; 2023; 107(1):29-34. PubMed ID: 36273445
[TBL] [Abstract][Full Text] [Related]
16. Utility of fluorescence in situ hybridization as a non-invasive technique in the diagnosis of upper urinary tract urothelial carcinoma.
Marín-Aguilera M; Mengual L; Ribal MJ; Musquera M; Ars E; Villavicencio H; Algaba F; Alcaraz A
Eur Urol; 2007 Feb; 51(2):409-15; discussion 415. PubMed ID: 17010508
[TBL] [Abstract][Full Text] [Related]
17. A Urine-based DNA Methylation Marker Test to Detect Upper Tract Urothelial Carcinoma: A Prospective Cohort Study.
Ghoreifi A; Ladi-Seyedian SS; Piatti P; Chew YC; Jara B; Sanossian L; Bhasin JM; Yamada T; Fuchs G; Bhanvadia S; Sotelo R; Hung A; Aron M; Desai M; Gill I; Daneshmand S; Liang G; Djaladat H
J Urol; 2023 May; 209(5):854-862. PubMed ID: 36795966
[TBL] [Abstract][Full Text] [Related]
18. [Numerical aberrations of chromosomes 11 and 17 detected by fish--fluorescence in situ hybridization combined with cytology in exfoliated cells from voided urine in patients with urothelial carcinoma of the bladder].
Asali MG; Kaneti J; Manor E
Harefuah; 2007 Dec; 146(12):914-9, 1000. PubMed ID: 18254439
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive Detection of Urothelial Carcinoma by Cost-effective Low-coverage Whole-genome Sequencing from Urine-Exfoliated Cell DNA.
Zeng S; Ying Y; Xing N; Wang B; Qian Z; Zhou Z; Zhang Z; Xu W; Wang H; Dai L; Gao L; Zhou T; Ji J; Xu C
Clin Cancer Res; 2020 Nov; 26(21):5646-5654. PubMed ID: 33037018
[TBL] [Abstract][Full Text] [Related]
20. Clinical utility and concordance of upper urinary tract cytology and biopsy in predicting clinicopathological features of upper urinary tract urothelial carcinoma.
Simon CT; Skala SL; Weizer AZ; Ambani SN; Chinnaiyan AM; Palapattu G; Hafez K; Magers MJ; Kaffenberger SD; Spratt DE; Montgomery JS; Morgan TM; Udager AM; Lew M; Mehra R
Hum Pathol; 2019 Apr; 86():76-84. PubMed ID: 30537495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
